The Jalisco Health Secretariat (SSJ) detected an outbreak of bloodstream infection (STIS) in 52 patients from various hospitals in the state.
The unit reported that patients were infected intravenously with the nosocomial bacterium Leclercia Adecarboxylata. Of the 52 cases, 23 were registered in IMSS hospitals; 19 in civilian hospitals; 7 in SSJ institutions, and 3 in private hospitals. Nine of the cases are concentrated in the metropolitan area of Guadalajara.
In press conference, the SSJ explained that 81% of the cases are babies less than one year old and the rest adults. All cases have something in common: they were in a parenteral nutrition treatment, that is, they received intravenous feeding because they are in serious health conditions that prevent them from eating otherwise.
The health authorities hypothesize that the outbreak may be due to a batch of infected material that was distributed in these hospitals in days gone by the SAFE, mixing center, which is a subsidiary of the pharmaceutical company PISA.
Until Wednesday, these 52 cases have been identified, but the health authorities maintain the inspection work before the possibility of new cases.
Infected patients present general malaise, fever, and chills.
The Secretary of Health of Jalisco, Fernando Petersen Aranguren, commented that since the outbreak was heard, the Federal Health secretariat has been informed and the necessary measures have been taken to assist it.
At the moment the health unit reports the death of a child under 9 days of age who apparently was also infected, although this will be confirmed in the following hours.
The health authorities that there could be more deaths among infected patients, especially because of the severity conditions they present, coupled with the presence of the virus.
Thank you for reading! Help us get on with our work. How? Now you can subscribe to the political Animal on Facebook. With your monthly donation you will receive special content. Find out how to subscribe here. Check out our list of frequently asked questions here.